OCA

Liana Moussatos of Wedbush overviewed the emerging pharmaceuticals space and offered a scenario analysis of various potential catalysts. Moussatos has the highest degree of confidence on two upcoming catalysts for Relypsa Inc (NASDAQ: RLYP), one of which could see its stock move up or down by as...

The following represents a hand-picked selection of notable research curated by an analyst known in some circles as "The Sith Overlord Of The Street." Morgan Stanley: Initiating Intercept Pharmaceutical At Underperform Andrew Berens of Morgan Stanley initiated coverage of Intercept Pharmaceuticals...

U.S. stocks rose as investors focused on positive economic data rather than the tense situation in Ukraine. Economic reports showed that U.S. industrial production rose in February. President Obama imposed sanctions against Russian and Crimea officials following an election on Sunday which...

Here's a look at the top tickers trending on StockTwits.com. Intercept Pharmaceuticals: Phase III trial update Intercept Pharmaceuticals (NASDAQ: ICPT) announced hat its liver disease drug obeticholic acid (OCA) for primary biliary cirrhosis has been successful in its POISE phase III clinical...

The market picked up where it left off Tuesday and recorded a second straight day of strong gains. The Dow posted a triple digit point gain while the S&P 500 and Nasdaq all gained as the Federal Reserve's Beige Book indicated that economic growth remained healthy in most U.S. regions. The...